Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Let-7b helps alpaca hair grow by reducing TGFβR I protein.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Hair color is determined by melanin produced and transferred in hair follicles.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Melatonin applied to the scalp helps treat early-stage hair loss in men and women.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Bee pollen, green tea, essential oils, and various plant extracts improve skin and hair health.

The document is a detailed medical reference on skin and genetic disorders.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Follicular unit hair transplantation is the standard method for natural-looking hair restoration in androgenic alopecia.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Androgens may influence bladder cancer progression by affecting cellular behavior.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.